Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109970795A details a novel iridium catalyst achieving 98% ee. Discover cost reduction in chiral ligand manufacturing and supply chain advantages.
Patent CN118791432A enables high-purity Rimegepant intermediate synthesis via low-loading catalyst. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102951980A reveals a novel iridium-catalyzed method for producing chiral amines, offering significant cost reduction in agrochemical intermediate manufacturing and scalable supply chain solutions.
Patent CN108083980B details a high-yield L-menthol process using chiral phosphine ligands, offering stable supply and cost reduction in flavors manufacturing.
Patent CN112028727A details a robust Pd-catalyzed route for chiral indolines, offering high enantioselectivity and scalable manufacturing for pharmaceutical intermediates.
Patent CN115803318A details an enantioselective route for high-purity tetrahydroquinoline intermediates, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN112209967B reveals high-yield ligand synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103917096A details improved asymmetric hydrogenation for opioid antagonists. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel asymmetric hydrogenation route for sitagliptin intermediate CN106146340B. High ee value >99%, cost-effective manufacturing, reliable supply chain solution.
Patent CN115448813B details a manganese-catalyzed route for Crizotinib intermediates. Achieves 95% ee with reduced costs and scalable mild conditions for global supply chains.
Patent CN117003651B breakthrough. Safer transfer hydrogenation. Cost reduction in pharma intermediate manufacturing. High-purity L-epinephrine production.
Patent CN109956946B details a novel iridium-catalyzed method for synthesizing chiral amines with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108299342B details a cost-effective synthesis of (2S,3R)-2,3-epoxy-1-tetradecanol using nickel boride catalysis, offering significant supply chain advantages.
Patent CN104936938B reveals efficient asymmetric hydrogenation reducing catalyst usage. Enhances supply chain reliability for vitamin intermediates manufacturing.
Novel asymmetric reduction route ensures high ee value and yield for Tegoprazan intermediate, offering significant supply chain stability and cost optimization for global pharmaceutical manufacturing partners.
Patent CN1753857A details a recyclable sulfonated BINAP-Ru catalyst for high-purity carboxylic acid production, offering significant cost reduction and simplified separation.
Patent CN103415524B details stereoselective reduction for dorzolamide intermediates. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110156645B details a streamlined 2-step asymmetric synthesis for florfenicol intermediates, drastically cutting waste and costs while ensuring high optical purity for veterinary pharmaceutical manufacturing supply chains.
Patent CN103889995B reveals a breakthrough ruthenium catalyst for asymmetric hydrogenation, offering enhanced solvent flexibility and supply chain reliability for chiral alcohol production.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.